Mechanism of action: rasburicase and allopurinol.

Depicted is the pathway of purine catabolism. Rasburicase is a recombinant form of urate oxidase, an enzyme that converts uric acid to allantoin. Allopurinol in comparison acts by inhibiting the endogenous enzyme xanthine oxidase, thereby inhibiting formation of uric acid.